Correlation of endothelial nitric oxide synthase and vascular endothelial growth factor expression with malignancy in patients with astrocytic tumors

Journal of B.U.ON.

Volumn 11, Issue 2, 2006, Pages 213-216

  Erdamar, S ^a   Bagci, Pelin ^a   Oz, B ^a   Dirican, A ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Astrocytic tumor; Endothelial nitric oxide synthase (eNOS); Immunohistochemistry; Vascular endothelial growth factor (VEGF)

Indexed keywords

AVIDIN; BIOTIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FREE RADICAL; KI 67 ANTIGEN; MONOCLONAL ANTIBODY; NITRIC OXIDE; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; ASTROCYTOMA; BLOOD VESSEL PERMEABILITY; BRAIN CANCER; CANCER CELL; CANCER GRADING; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME SYNTHESIS; GENE OVEREXPRESSION; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; OLIGODENDROGLIOMA; PHENOTYPE; PROTEIN EXPRESSION; TISSUE SECTION; TUMOR NECROSIS; TUMOR VASCULARIZATION; VASODILATATION;

ADULT; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33751039996     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bakshi A, Nag TC, Wadhwa S, Mahapatra AK, Sarkar C. The expression of nitric oxide synthases in human brain tumors and peritumoral areas. J Neurol Sci 1998; 155: 196-203.
2. Iwata S, Nakagawa K, Harada. H, Oka Y, Kumon Y, Sakaki S. Endothelial nitric oxide synthase expression in tumor vasculature is correlated with malignancy in human supratentorial astrocytic tumors. Neurosurgery 1999; 45: 24-28.
3. Blais V, Rivest S. Inhibitory action of nitric oxide on circulating tumor necrosis factor-induced NF-kappa B activity and COX-2 transcription in the endothelium of the brain capillaries. J Neuropathol Exp, Neurol 2001; 60: 893-905.
4. Merrill MJ, Oldfield EH. A reassessment of vascular endothelial growth factor in central nervous system pathology. J Neurosurg 2005; 103: 853-868.
5. Huang H, Held-Feindt J, Buhl R, Mehdorn HM, Mentlein R. Expression of VEGF and its receptors in different brain tumors. Neurol Res 2005; 27: 371-377.
6. Miyagami M, Katayama Y. Angiogenesis of glioma: evaluation of ultrastructural characteristics of microvessels and tubular bodies (Weibel-Palade) in endothelial cells and immunohistochemical findings with VEGF and p53 protein. Med Mol Morphol 2005; 38: 36-42.
7. Saleem IA, Edvardsen K, Ho LK, Yang YX, Rock JP, Rosenblum ML. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma. J Neurosurg 1998; 88: 513-520.
8. Lamszus K, Ulbricht U, Matschke J, Brockmann MA, Fillbrandt R, Westphal M. Levels of soluble vascular endothelial growth factor receptor 1 in astrocytic tumors and its relation to malignancy, vascularity and VEGF-A. Clin Cancer Res 2003; 9: 1399-1405.
9. Berkman RA. Expression of the VEGF gene in central nervous system neoplasms. J Clin Invest 1993; 91: 153-159.
10. Li WV, Folkerth RD, Watanabe H et al. Microvessel count and cerebrospinal fluid basic fibroblastic growth factor in children with brain tumours. Lancet 1994; 344: 82-86.
11. Pietsch T, Valter MM, Wolf HK et al. Expression and distribution of vascular endothelial growth factor protein in human brain tumors. Acta Neuropathol 1997; 93: 109-117.
12. Broholm H, Rubin I, Kruse A et al. Nitric oxide synthase expression and enzymatic activity in human brain tumors. Clin Neuropathol 2003;22:273-281.
13. Anggard E. Nitric oxide: mediator, murderer and medicine. Lancet 1994; 343: 1199-1206.
14. Cobbs CS, Brenman JE, Aldape KD, Bredt DS, Israel MA. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res 1995; 55: 727-730.
15. De Groot CJA, Ruuls SR, Theeuwes JWM, Dukstra CD, Van Der Valk P. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions.